{"schema_version":"secwatch.filing_event.v1","accession":"0001289848-22-000006","form_type":"8-K","ticker":"HURN","cik":"0001289848","company_name":"Huron Consulting Group Inc.","filed_at":"2022-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.798983+00:00","generated_at":"2026-06-27T04:38:16.607313+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Huron Q4 revenue up 25% to $248M, full year 2021 adjusted EPS $2.61; guides FY22 revenue $970M-$1.03B","bullets":["Q4 revenue $248.3M (+25.2% YoY); GAAP diluted EPS $1.45 vs -$0.28; adjusted diluted EPS $0.80 vs $0.45.","Full year 2021 revenue $905.6M (+7.3%); GAAP diluted EPS $2.89 vs -$1.08; adjusted diluted EPS $2.61 vs $2.15.","Full year adjusted EBITDA $97.8M (+12.3%); 2022 revenue guidance $970M-$1.03B.","Q4 includes $23.7M after-tax gain from sale of Life Sciences business.","New operating model effective Jan 1, 2022 to integrate industry expertise with digital/strategic capabilities."],"urls":{"canonical":"https://secwatch.observer/filing/0001289848-22-000006","json":"https://secwatch.observer/filing/0001289848-22-000006.json","markdown":"https://secwatch.observer/filing/0001289848-22-000006.md","text":"https://secwatch.observer/filing/0001289848-22-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1289848/000128984822000006/0001289848-22-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1289848/000128984822000006/hurn-20220224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T04:38:16.607313+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}